Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Shares Outstanding (Weighted Average) (2021 - 2026)

HeartSciences (HSCS) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 128.57% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Oct 2025, up 128.57%, and an annual FY2025 reading of $938257.0, up 166.16% over the prior year.
  • Shares Outstanding (Weighted Average) was $2.1 million for Q4 2025 at HeartSciences, up from $1.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $8.2 million in Q4 2022 and bottomed at $79506.0 in Q2 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $2.4 million, with a median of $1.1 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Weighted Average) crashed 98.7% in 2023, then soared 760.79% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $3.3 million in 2021, then skyrocketed by 147.76% to $8.2 million in 2022, then plummeted by 98.7% to $106582.0 in 2023, then skyrocketed by 760.79% to $917445.0 in 2024, then soared by 128.57% to $2.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for HSCS at $2.1 million in Q4 2025, $1.3 million in Q3 2025, and $938257.0 in Q2 2025.